Type-2 Diabetes Mellitus and Cardiovascular Disease

References

• Global Report on Diabetes . World Health Organization . Diabetes Fact Sheet, ISBN 978 92 4 156525 7 (NLM classification: WK 810) ( 2016 ). https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=69071D7B7A452E8DF854B6A40?sequen .
   Google Scholar
• Beagley J , GuariguataL, WeilC, MotalaAA . Global estimates of undiagnosed diabetes in adults . Diabetes Res. Clin. Pract.103 ( 2 ), 150 – 160 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gakidou E , MallingerL, Abbott-KlafterJet al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys . Bull. World Health Organ.89 ( 3 ), 172 – 183 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Noncommunicable Disease Risk Factor Collaboration (NCD-RisC) . Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants . Lancet387 ( 10027 ), 1513 – 1530 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bloom D , CafieroE, Jané-LlopisEet al. The global economic burden of noncommunicable diseases (Working Paper Series) . Presented at : Harvard School of Public Health and World Economic Forum . Geneva, Switzerland, 19–20 September 2011 .
   Google Scholar
• Dabelea D . The accelerating epidemic of childhood diabetes . Lancet373 ( 9680 ), 1999 – 2000 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Imamura F , O’ConnorL, YeZet al. Consumption of sugar-sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction . BMJ351, h3576 ( 2015 ).
   PubMedGoogle Scholar
• Turner R , MillinsH, NeilHet al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) the United Kingdom Prospective Diabetes Study Group . BMJ316, 823 – 828 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Sarwar N , GaoP, SeshasaiSR, GobinR, KaptogeS, Di AngelantonioE . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies . Lancet375 ( 9733 ), 2215 – 2222 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Singh G , DanaeiG, FarzadfarFet al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis . PLoS ONE8 ( 7 ), e65174 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Danaei G , LawesC, VanderHS, MurrayCJ, EzzatiM . Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment . Lancet368 ( 9548 ), 1651 – 1659 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Beckman J , CreagerM, LibbyP . Diabetes mellitus: epidemiology, pathophysiology, and management . JAMA287 ( 19 ), 2570 – 2581 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Vazquez-Benitez G , DesaiJR, XuSet al. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis . Diabetes Care38 ( 5 ), 905 – 912 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Moe B , EilertsenE, NilsenT . The combined effect of leisure-time physical activity and diabetes on cardiovascular mortality: the Nord-Trondelag Health (HUNT) cohort study, Norway . Diabetes Care36 ( 3 ), 690 – 695 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zoungas S , WoodwardM, LiQet al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes . Diabetologia57 ( 12 ), 2465 – 2474 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• The Advance Cooperative Group . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes . N. Engl. J. Med.358 ( 24 ), 2560 – 2572 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Wackers F , YoungL, InzucchiSet al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects. The DIAD study . Diabetes Care27 ( 8 ), 1954 – 1961 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sassoc F , FurbattoF, CarbonaraOet al. Prevalence of diabetes in patients with nonacute CAD . Acta Diabetol.48 ( 3 ), 247 – 248 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• McGinn J , ShariffM, BhatTet al. Prevalence of dysglycemia among coronary artery bypass surgery patients with no previous diabetic history . J. Cardiothorac. Surg.6, 104 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Turnbull F , AbrairaC, AndersonRet al. Intensive glucose control and macrovascular outcomes in type 2 diabetes . Diabetologia52 ( 11 ), 2288 – 2298 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Skyler J , BergenstalR, BonowR . Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials . Circulation119 ( 2 ), 351 – 357 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Herman W , YeW, GriffinSet al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe) . Diabetes Care38 ( 8 ), 1449 – 1455 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Inge T , KingW, JenkinsTet al. The effect of obesity in adolescence on adult health status . Pediatrics132, 1098 – 1104 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hales C , CarrollM, FryarC, OgdenC . Prevalence of obesity among adults and youth: United States, 2015–2016 . National Center for Health Statistics Data Brief . 288, 1 – 8 ( 2017 ).
   Google Scholar
• Sluik D , BoeingH, MontonenJet al. Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus . Am. J. Epidemiol.174, 22 – 34 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Whitlock G , LewingtonS, SherlikerPet al. Prospective Studies Collaboration . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies . Lancet373 ( 9669 ), 1083 – 1096 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 . BMJ317, 703 – 713 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• The ACCORD Study Group . Effects of intensive blood-pressure control in type 2 diabetes mellitus . N. Engl. J. Med.362, 1575 – 1585 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Leon B , MaddoxT . Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research . World J. Diabetes6 ( 13 ), 1246 – 1258 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Whelton P , CareyR, AronowWet al. CC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults . J. Am. Coll. Cardiol.71 ( 19 ), e127 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Taylor F , HuffmanMD, MacedoAFet al. Statins for the primary prevention of cardiovascular disease . Cochrane Database Syst. Rev.1, CD004816 ( 2013 ).
   PubMedGoogle Scholar
• Baigent C , KeechA, KearneyPMet al. Cholesterol Treatment Trialists’ (CTT) Collaborators . Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins . Lancet366 ( 9493 ), 1267 – 1278 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Collins R , ArmitageJ, ParishS, SleighP, PetoR . Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial . Lancet361 ( 9374 ), 2005 – 2016 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Kearney PM , BlackwellL, CollinsRet al. Cholesterol Treatment Trialists’ collaborators, efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis . Lancet371 ( 9607 ), 117 – 125 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Colhoun H , BetteridgeD, DurringtonPet al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial . Lancet364 ( 9435 ), 685 – 696 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sattar N , PreissD, MurrayHet al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials . Lancet375 ( 9716 ), 735 – 742 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Olafsdottir E , AspelundT, SigurdssonGet al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik study . BMJ Open1 ( 1 ), e000132 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Willi C , BodenmannP, GhaliWA, FarisPD, CornuzJ . Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis . JAMA298 ( 22 ), 2654 – 2664 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Jankowich M , ChoudharyG, TaveiraT, WuW-C . Age-, race-, and gender-specific prevalence of diabetes among smokers . Diabetes Res. Clin. Pract.93, e101 – e105 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cowie C , RustK, Byrd-HoltDet al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006 . Diabetes Care33 ( 3 ), 562 – 568 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Herman W , KalyaniR, CherringtonA . American diabetes association standards of medical care in diabetes . Diabetes Care40 ( Suppl. 1 ), S1 – S132 ( 2017 ).
   PubMedGoogle Scholar
• Rask-Madsen C , KingG . Vascular complications of diabetes: mechanisms of injury and protective factors . Cell Metab.17 ( 1 ), 20 – 33 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Schmidt AM , SternD . Atherosclerosis and diabetes: the RAGE connection . Curr. Atheroscler. Rep.2 ( 5 ), 430 – 436 ( 2000 ).
   PubMedGoogle Scholar
• Petersen KF , DufourS, BefroyD, GarciaR, ShulmanGI . Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes . N. Engl. J. Med.350 ( 7 ), 664 – 671 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Creager M , LuscherT, CosentinoF, BeckmanJ . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I . Circulation108 ( 12 ), 1527 – 1532 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Kim JK . Endothelial nuclear factor kappa B in obesity and aging: Is endothelial nuclear factor kappa B a master regulator of inflammation and insulin resistance?Circulation125 ( 9 ), 1081 – 1083 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Li Y , WooV, BoseR . Platelet hyperactivity and abnormal Ca(2) homeostasis in diabetes mellitus . Am. J. Physiol. Heart Circ. Physiol.280 ( 4 ), H1480 – H1489 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Trayhurn P , WoodIS . Signaling role of adipose tissue: adipokines and inflammation in obesity . Biochem. Soc. Trans.33 ( Pt 5 ), 1078 – 1081 ( 2005 ).
   PubMedGoogle Scholar
• Rosenson RS . Clinical role of LDL and HDL subclasses and apolipoprotein measurement . ACC Curr. J. Rev.13 ( 5 ), 33 – 37 ( 2004 ).
   Google Scholar
• Libby P , RidkerPM, MaseriA . Inflammation and atherosclerosis . Circulation105 ( 9 ), 1135 – 1143 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Zampetaki A , KiechlS, DrozdovIet al. Plasma microRNA profiling reveals loss of endothelial mir-126 and other microRNAs in type 2 diabetes . Circ. Res.107 ( 6 ), 810 – 817 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Caporali A , MeloniM, VollenkleCet al. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia . Circulation123 ( 3 ), 282 – 291 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yahagi K , KolodgieF, LutterCet al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus . Arterioscler. Thromb. Vasc. Biol.37 ( 2 ), 191 – 204 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Jensen M , RyanD, ApovianCet al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society . Circulation129, S102 – S138 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Knowler WC , Barrett-ConnorE, FowlerSet al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin . N. Engl. J. Med.346 ( 6 ), 393 – 403 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Fox C , GoldenS, AndersonCet al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence. A scientific statement from the American Heart Association and the American Diabetes Association . Circulation132 ( 8 ), 691 – 718 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sjöström L , LindroosA, PeltonenMet al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery . N. Engl. J. Med.351 ( 26 ), 2683 – 2693 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Carlsson LM , PeltonenM, AhlinSet al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects . N. Engl. J. Med.367 ( 8 ), 695 – 704 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Clair C , RigottiNA, PornealaBet al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes . JAMA309 ( 10 ), 1014 – 1021 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lewington S , ClarkeR, QizilbashN, PetoR, CollinsR . Prospective Studies Collaboration . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies . Lancet360 ( 9349 ), 1903 – 1913 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Emdin CA , RahimiK, NealB, CallenderT, PerkovicV, PatelA . Blood pressure lowering in type 2 diabetes: a systematic review and metaanalysis . JAMA313 ( 6 ), 603 – 615 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Arguedas JA , LeivaV, WrightJM . Blood pressure targets for hypertension in people with diabetes mellitus . Cochrane Database Syst. Rev.10, CD008277 ( 2013 ).
   Google Scholar
• Whelton P , CareyR, AronowWet al. 2017 Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults . J. Am. Coll. Cardiol.71 ( 19 ), 2199 – 2269 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Kirkman MS , BriscoeVJ, ClarkNet al. Diabetes in older adults . Diabetes Care35 ( 12 ), 2650 – 2664 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Heart Outcomes Prevention Evaluation Study Investigators . Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy . Lancet355 ( 9200 ), 253 – 259 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Palmer S , MavridisD, NavareseEet al. Comparative efficacy and safety of blood pressure lowering agents in adults with diabetes and kidney disease: a network meta-analysis . Lancet385 ( 9982 ), 2047 – 2056 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Peters S , HuxleyR, WoodwardM . Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events . Diabetologia57 ( 8 ), 1542 – 1551 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kalyani R , LazoM, OuyangPet al. Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults . Diabetes Care37 ( 3 ), 830 – 838 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bhatt DL , BonacaM, BansilalSet al. Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54 . J. Am. Coll. Cardiol.67 ( 23 ), 2732 – 2740 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Defronzo RA . Banting lecture: From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus . Diabetes58 ( 4 ), 773 – 795 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gerstein H , MillerM, ByingtonRet al. Effects of intensive glucose lowering in type 2 diabetes . N. Engl. J. Med.358 ( 24 ), 2545 – 2559 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Qaseem A , WiltT, KansagaraDet al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians . Ann. Intern. Med.168 ( 8 ), 569 – 576 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Madiraju AK , ErionDM, RahimiYet al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase . Nature510 ( 7506 ), 542 – 546 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hong J , ZhangY, LaiSet al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease . Diabetes Care36 ( 5 ), 1304 – 1311 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lipska K , BaileyC, InzucchiS . Use of metformin in the setting of mild-to-moderate renal insufficiency . Diabetes Care34 ( 6 ), 1431 – 1437 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Inzucchi S , BergenstalR, BuseJet al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach . Diabetes Care35 ( 6 ), 1364 – 1379 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Inzucchi S . Personalizing glucose-lowering therapy in patients with type 2 diabetes and cardiovascular disease . Endocrinol. Metab. Clin. North Am.47 ( 1 ), 137 – 152 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Dormandy J , CharbonnelB, EcklandDet al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macrovascular Events): a randomised controlled trial . Lancet366 ( 9493 ), 1279 – 1289 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Nathan D , BuseJ, KahnSet al. Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) . Diabetes Care36 ( 8 ), 2254 – 2261 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Marso S , DanielsG, Brown-FrandsenKet al. Liraglutide and cardiovascular outcomes in type 2 diabetes . N. Engl. J. Med.375 ( 4 ), 311 – 322 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Inzucchi S , BergenstalR, BuseJet al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach . Diabetes Care38 ( 1 ), 140 – 149 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zinman B , WannerC, LachinJet al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes . N. Engl. J. Med.373 ( 22 ), 2117 – 2128 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Neal B , PerkovicV, MahaffeyKet al. Canagliflozin and cardiovascular and renal events in type 2 diabetes . N. Engl. J. Med.377 ( 7 ), 644 – 657 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee . Pharmacologic management of type 2 diabetes: 2016 interim update . Can. J. Diabetes40 ( 3 ), 193 – 195 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zoungas S , PatelA, ChalmersJet al. Severe hypoglycemia and risks of vascular events and death . N. Engl. J. Med.363, 1410 – 1418 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Holman R , ThorneK, FarmerAet al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes . N. Engl. J. Med.357, 1716 – 1730 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Timmer J , OttervangerJ, de BoerMet al. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial . Arch. Intern. Med.167 ( 13 ), 1353 – 1359 ( 2007 ).
   PubMedGoogle Scholar
• Stone GW , GrinesCL, CoxDAet al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction . N. Engl. J. Med.346, 957 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Kundu A , SardarP, O’DayK . SYNTAX score and outcomes of coronary revascularization in diabetic patients . Curr. Cardiol. Rep.20 ( 5 ), 28 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Jiang Y-J , HanW-X, GaoCet al. Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China. A retrospective study . Medicine96 ( 17 ), e6647 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Ledru F , DucimetiereP, BattagliaSet al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study . J. Am. Coll. Cardiol.37 ( 6 ), 1543 – 1550 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Goraya T , LeibsonC, PalumboPet al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study . J. Am. Coll. Cardiol.40 ( 5 ), 946 – 953 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Silva J , EscobarA, CollinsTJet al. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients . Circulation92, 1731 – 1736 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Cola C , BrugalettaS, Martin YusteVet al. Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization . Vasc. Health Risk Manag.5 ( 1 ), 101 – 119 ( 2009 ).
   PubMedGoogle Scholar
• Kornowski R , MintzG, KentKet al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study . Circulation95 ( 6 ), 1366 – 1369 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• The Bypass Angioplasty Revascularization Investigation (BARI) . Influence of diabetes on 5-year mortality in a randomized trial comparing CAGB and PTCA in patients with multivessel disease . Circulation96 ( 6 ), 1761 – 1769 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Abizaid A , CostaMA, CentemeroMet al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularizations Therapy Study (ARTS) trial . Circulation104 ( 5 ), 533 – 538 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Hueb W , SoaresP, GershB . The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results . J. Am. Coll. Cardiol.43 ( 10 ), 743 – 751 ( 2004 ).
   Web of Science ®Google Scholar
• Farkouh M , DomanskiM, SleeperLet al. Strategies for multivessel revascularization in patients with diabetes . N. Engl. J. Med.367 ( 25 ), 2375 – 2384 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Habib R , DimitrovaK, BadourSet al. Greater benefit in long-term outcomes with multiple arterial bypass grafting . J. Am. Col. Cardiol.66 ( 13 ), 1417 – 1427 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Raza S , BlackstoneE, HoughtalingPet al. Similar outcomes in diabetes patients after coronary artery bypass grafting with single internal thoracic artery plus radial artery grafting and bilateral internal thoracic artery grafting . Ann. Thorac. Surg.104 ( 6 ), 1923 – 1932 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Pevni D , MedalionB, MohrRet al. Should bilateral internal thoracic artery grafting be used in patients with diabetes mellitus? Ann. Thorac. Surg. 103 ( 2 ), 551 – 558 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• McGrath B , NorrisC, Hardwicke-BrownEet al. Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study . Eur. Heart J. Qual. Care Clin. Outcomes3 ( 3 ), 216 – 223 ( 2017 ).
   PubMedGoogle Scholar
• Maggioni AP , GreeneSJ, FonarowGCet al. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial . Eur. Heart J.34 ( 40 ), 3117 – 3127 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bertoni AG , HundleyWG, MassingMW, BondsDE, BurkeGL, GoffDCJr . Heart failure prevalence, incidence, and mortality in the elderly with diabetes . Diabetes Care27 ( 3 ), 699 – 703 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Greene S , VaduganathanM, KhanM . Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes . J. Am. Coll. Cardiol.71 ( 12 ), 1379 – 1390 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Paulus W , Dal CantoE . Distinct myocardial targets for diabetes therapy in heart failure with preserved or reduced ejection fraction . J. Am. Coll. Cardiol. Heart Failure6, 1 – 7 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Yancy C , JessupM, BozkurtBet al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure . Circulation136, e137 – e161 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Ponikowski P , VoorsAA, AnkerSDet al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology . Eur. J. Heart Fail.18 ( 8 ), 891 – 975 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bruni A , Gala-LopezB, PepperAet al. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges . Diabetes Metab. Syndr. Obes.7, 211 – 223 ( 2014 ).
   PubMedGoogle Scholar
• Voltarelli J , CouriC, StracieriAet al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus . JAMA297 ( 14 ), 1568 – 1576 ( 2007 ).
   PubMed Web of Science ®Google Scholar